| 27th week of 2015 patent applcation highlights part 7 |
| Patent application number | Title | Published |
|---|
| 20150182398 | APPARATUS FOR SELECTIVELY SUPPORTING A BED SECTION - Apparatus for selectively supporting a section ( | 2015-07-02 |
| 20150182399 | ADJUSTABLE BED SYSTEM WITH SPLIT HEAD AND SPLIT FOOT CONFIGURATION - A sleep system comprises an air posturizing module having a case, the case comprising a first case section extending medially along a length of the case to define a movable first section, a second case section adjacent to the first case section and extending along a length of the case to define a movable second section, a third case section defining a third posturing section, a fourth case section extending medially along a length of the case to define a movable third section, and a fifth case section extending medially along a length of the case to define a movable fourth section. One or more first air chambers are carried in the first, third and fourth case sections to provide a first sleep area, and one or more second air chambers are carried in the second, third, and fifth module sections to provide a second sleep area. | 2015-07-02 |
| 20150182400 | PATIENT SUPPORT SYSTEMS AND METHODS OF USE - The present disclosure relates to patient support systems, such as hospital beds, and particularly to reconfigurable patient support systems movable among a number of different positions. The present disclosure further relates to control algorithms and interfaces for use in patient support systems. | 2015-07-02 |
| 20150182401 | LATCHING MOTION TRANSFER MECHANISM - Latching motion transfer arrangements may be used to raise an object up and out of the engagement with the ground or other support surface and to lower the object back onto the ground or other support surface. In one exemplary embodiment, the mechanism is caused to lift and latch by applying force in a first direction, a first time, and is caused to release and lower by applying force in the first direction, a second time. | 2015-07-02 |
| 20150182402 | Devices and Methods for Lift Assistance and Waste Control - Devices and methods are disclosed which relate to lifting a user from a seated position to a raised position. This is performed by incorporating a lifting mechanism into a seat coupled to a movable base portion. As the lifting portion lifts the seat, an angle of the seat changes from a substantially horizontal position to a relatively angled position, mimicking the natural motion of the hips and thighs for humans needing assistance. Embodiments disclosed include using the device as a bedside toilet, having a removable bucket attached to the seat, or using the device placed over a toilet. The removable bucket may be a drop-in commode bucket, or a splash guard having no bottom for use over the toilet. The seat may be built flush to a seating platform base, enabling easy cleaning, and accommodating users of various shapes and sizes. | 2015-07-02 |
| 20150182403 | A Mobile Robotic Lifting and Transferring System for Bariatric Patients - Obesity has grown into one of the world's most significant health problems. The field of bariatrics and the quantity of bariatric surgical procedures is projected to continue to increase rapidly each year. This trend presents a challenge to healthcare providers and facilities striving to provide dignified care that is effective and safe both for the patient and the provider. There is a great demand for new approaches to bariatric patient care. The present invention is a robotic patient lifting system, targeted for, but not limited to, bariatric patient care. Without the need for difficult, time consuming slings and hoists associated with currently available systems, the invented lifting and transferring system utilizes rapidly deployable, articulated robotic arms with gentle conveyor belts. A unique linkage system allows powerful, safe, and flexible lifting and positioning of the patient with a minimal number of actuators. The lifting mechanism is mounted on a low profile, stable and flexible footprint, omnidirectional robotic mobile base. A simple, intuitive user interface allows control by a single caregiver with minimal training | 2015-07-02 |
| 20150182404 | Patient Positioning Device - A patient positioning device for restoring a patient to a desired position in a hospital bed. An example patient positioning device may include a flexible track positioned along each of the lateral edges of a sleep surface and extending substantially the entire length of the sleep surface, a sheet including beaded edges for slidably engaging the tracks such that the sheet spans between the first track and the second track on the sleep surface, and/or a drive mechanism located proximate a head end of the sleep surface and configured to pull the sheet towards the head end of the bed. | 2015-07-02 |
| 20150182405 | AUTOMATIC WATERLESS TOILET SYSTEM WITH A DISPOSABLE SEALABLE LINER - An automatic waterless toilet system comprises a reusable bedpan implement for raising a patient and a disposable collapsible liner to collect human waste therein. The liner is a rigid tray or a flexible bag insertable into the bedpan implement from one side. The bedpan implement has a motorized slider sub-system for automatic engaging and pulling the liner into a working position inside the implement and aligning thereof with a central opening in the bedpan implement and under the patient. After collection of waste within the disposable liner, it is automatically sealed and ejected from the bedpan implement such that the caregiver is protected from having to see, smell or handle an open container with human waste. The liner is made collapsible with an air escape so as to minimize its volume upon compression. The invention may be used as an alternative sewer collection system. | 2015-07-02 |
| 20150182406 | MULTIPLE PATIENT INFANT WARMING DEVICE, MANAGER AND METHOD - A multiple patient infant warming management system comprises at least one temperature sensor for sensing at least one temperature of an infant warming device and a controller. The controller processes first signals for different temperature ranges of different temperature zones assigned to different patients to be concurrently warmed the infant warming device, receives second signals from the at least one temperature sensor indicating at least one temperature of the infant warming device and outputs adjustments based on the first signals and the second signals. | 2015-07-02 |
| 20150182407 | PACKAGING SHEETS, PACKAGING MATERIALS AND RELATED METHODS - Packaging sheets, packaging material comprise one or more packaging sheets and related methods are provided herein. A packaging sheet can include a first substrate having a first surface and an opposing second surface. An adhesive layer can be applied on the first surface of the first substrate. A cohesive layer can he applied on the adhesive layer, such that the cohesive forms a first outer surface of the packaging sheet with the opposing second surface of the first substrate forming a second outer surface. The packaging sheets can, in some embodiments, comprise body bag sheets used to form body bags. | 2015-07-02 |
| 20150182408 | MOTION ASSISTIVE APPARATUS AND METHOD OF CONTROLLING THE SAME - A motion assistive apparatus may include a receiver allowing a user to intuitively adjust performance of the motion assistive apparatus and a method of controlling the same. The motion assistive apparatus may include a receiver provided to adjust variable characteristics of the motion assistive apparatus, a processor to adjust a variable parameter related to adjustment of the variable characteristics, in response to adjustment of the variable characteristics through the receiver, and an actuator to output changed assist power in response to adjustment of the variable parameter to change the variable characteristics. | 2015-07-02 |
| 20150182409 | DUAL DENSITY PRESSURE PAD - Provided are orthopedic, dual density pressure pads designed to transfer pressure onto a focused anatomical structure; typically through the assistance of a device that applies a perpendicular or downward force. The pad includes an outer layer including a relatively soft material and an interior support including a rigid material, with the interior support typically having a substantially greater hardness than the outer layer. | 2015-07-02 |
| 20150182410 | PNEUMATIC WRAP COMPRESSION TREATMENTS FOR VENOUS CONDITIONS - A method of treatment of a condition such as deep vein thrombosis, arterial insufficiency, lymphedema, pulmonary embolism, and pain includes use of a pneumatic compression wrap, pump, and medicament to provide compression on the body part of a patient and a pharmaceutical beneficial in treating the condition. Deep vein thrombosis, arterial insufficiency, lymphedema, pulmonary embolism, and pain can also be treated by an electrotherapy device utilizing a hydrogel patch containing a medicament. Apparatus and systems for performing the methods of treatment can be utilized. | 2015-07-02 |
| 20150182411 | MASSAGE APPARATUS HAVING MASSAGE PRESSURE SENSING AND ADAPTING DEVICE MECHANISM - Disclosed is a massage apparatus having a massage pressure sensing and adapting drive mechanism ( | 2015-07-02 |
| 20150182412 | STIMULATION APPARATUS - Apparatus and methods for use of apparatus for applying targeted stimulation at or adjacent the base of the area of the glans of the penis, wherein the apparatus comprises a contact portion having a first contact surface conforming substantially to the longitudinal profile of the penis, the contact portion further having a second contact surface, raised, in use, inwardly of the first contact surface towards the penis, to project in use into positive engagement with the area at or adjacent the base of the glans of the penis are provided. | 2015-07-02 |
| 20150182413 | Vibrator - A vibrator for delivering distributed vibrations over a diffuse area of a human body. The vibrator includes a vibration head operable to deliver vibrations to a first region of the body, and one or more flexible elements disposed on one or more sides of the vibration head. The one or more flexible elements are operable to deliver vibrations to one or more additional body areas on one or more sides of the first body region. The one or more flexible elements are sufficiently compliant to conform to a contour of the one or more additional areas and lie in substantially contacting engagement against surfaces thereof along substantially the entire length of each flexible element. | 2015-07-02 |
| 20150182414 | System and Method for Eyelid Stimulation - A system and method of treating hyperactivity of an eyelid closing muscle in a subject includes providing a stimulation system in the subject with the hyperactivity of the eyelid closing muscle, sensing an activity of the eyelid closing muscle, and selectively stimulating eyelid opening muscle(s) or innervating nerves, eyelid opening reflexes, or eyelid opening reflexes in non-muscular tissue, using the stimulation system, without substantially activating the eyelid closing muscle. The system and method evokes eyelid movement in the subject. | 2015-07-02 |
| 20150182415 | Eyelid Care Appliance - Disclosed herein is an improved eyelid care appliance and method of using such appliance for preventing and treating blepharitis and mammalian meibomian gland dysfunction caused by gland obstruction. The method and apparatus of the invention enable restoration and maintenance of eyelid hygiene and the natural flow of secretions from the meibomian glands. A preferred embodiment of the apparatus comprises an oscillating spongehead affixed to the distal end of the eyelid care appliance that is equipped with a video camera, near field communications link, and a display, thereby enabling a user to “fly” the spongehead onto an eyelid margin for self-administered cleaning of the user's eyelid margins. The spongehead can be impregnated with topical pharmacologic or cleansing agents to better facilitate cleaning and therapeutic efficacy. | 2015-07-02 |
| 20150182417 | BIOLOGICAL MEASUREMENT APPARATUS AND BIOLOGICAL STIMULATION APPARATUS - A biological measurement apparatus of this invention includes (i) a micro piezoelectric element for vibrating a nerve cell of a subject without coming in contact with the nerve cell, (ii) an electromagnetic wave antenna for receiving an electromagnetic wave generated by the nerve cell vibrated by the micro piezoelectric element, and (iii) a computer for measuring an electric charge of the nerve cell based on the electromagnetic wave received by the electromagnetic wave antenna. Further, this biological measurement apparatus includes an electromagnetic wave antenna for emitting an electromagnetic wave to a nerve cell. This configuration provides an apparatus capable of measuring an electrical activity of a nerve cell in a living organism in real time and three-dimensionally at a spatial resolution of a nerve cell size. Moreover, this configuration provides an apparatus capable of individually giving electrical stimulations to any desired cells in the subject. | 2015-07-02 |
| 20150182418 | MASSAGE FURNITURE ITEM AND METHOD OF OPERATION - A furniture item includes two massage elements that are each operated to generate a vibration that can be transmitted into the furniture item, where the vibrations create a joint vibrational wave. The frequency of each vibration can be continuously varied within a predetermined frequency range. The shifting frequencies of the massage elements cause the peaks and troughs of the wave of the vibrational wave to move across the furniture element to create the sensation of a moving vibration for a user resting on the furniture item. | 2015-07-02 |
| 20150182419 | MECHANICAL DEVICE TO PROVIDE AND ENHANCE EXTERNAL CHEST COMPRESSION FOR CARDIAC RESUSCITATION AND METHOD - A mechanical device for providing external chest compression for cardiac resuscitation, comprising, a first support member positionable horizontally and a second support member positionable vertically, where the first and second support members are rotationally connected together with a swivel attachment that permits the first support member to rotate in an arc with respect to the second support member in at least one of a vertical and horizontal plane for positioning the first support member over a horizontally positioned victim or to maneuver the first support member out of the operative field when not in use, wherein the swivel attachment allows the first support member to be operated in up and down singular strokes in a pumping motion. | 2015-07-02 |
| 20150182420 | FRONT PART FOR SUPPORT STRUCTURE FOR CPR - An embodiment of the support structure includes a back plate, a central part adapted to recite an automatic compression/decompression unit, and a front includes two legs coupled between the central part and the back plate. The support structure is arranged to automatically compress or decompress a patient's chest when the front part is attached to the back plate and when the compression/decompression unit is received in the central part. | 2015-07-02 |
| 20150182421 | SPECIMEN COLLECTION APPARATUS - A specimen collection apparatus is provided. The specimen collection apparatus may include a container, a funnel for removable insertion in an opening of the container, a funnel cover; a removable seal, and a dispensing apparatus sealed within the funnel cover in a reagent-specific atmosphere. The dispensing apparatus may include a cap, a reagent housing attached to the cap, and a reagent designed to liquefy a specimen, stabilize the pH of the liquefied specimen, and be compatible with diagnostic procedures. | 2015-07-02 |
| 20150182422 | Enteral Feed Cup - A large enteral feed cup large enough to contain an amount of fluid suitable for a single dose (nutrition and/or medicines) is described. The enteral feed cup can be free-standing on the proximal end so as to facilitate filling via an opening on the distal end. The distal end includes a resealable closure for an opening that can be quite large and thus can be easily filled with less chance of spillage. The free-standing design of the enteral feed cup can also allow for the cup to be used in any convenient location. | 2015-07-02 |
| 20150182423 | ANTIPERSPIRANT APPLICATION DEVICE INCLUDING A SKIN-ADHESIVE PATCH AND METHODS OF USING THE SAME - Antiperspirant application devices including antiperspirant compositions and methods of using the antiperspirant application devices are provided herein. In an embodiment, an antiperspirant application device includes a skin-adhesive, transdermal patch including an adhesive compound capable of adhesion to human skin and an antiperspirant active compound based upon an astringent metallic salt disposed within at least a portion of the skin-adhesive, transdermal patch. | 2015-07-02 |
| 20150182424 | AEROSOL ANTIPERSPIRANT WITH REDUCED RESIDUE - Materials and apparatus are provided for an aerosol antiperspirant composition with decreased residue transfer to fabric. The aerosol antiperspirant composition includes an active antiperspirant ingredient. The aerosol antiperspirant composition further includes a number of silicas. The aerosol antiperspirant composition further includes a polar emollient. The aerosol antiperspirant composition further includes a propellant. A manufacturing process for such an aerosol antiperspirant composition is also provided. | 2015-07-02 |
| 20150182425 | ANTIPERSPIRANT COMPOSITION WITH A MINERAL CLAY EMULSIFIER - Materials and apparatus are provided that exhibit increased efficacy. The apparatus includes an antiperspirant composition with a mineral clay emulsifier. The antiperspirant composition includes a water-in-oil emulsion. The water-in-oil emulsion includes a water-phase component that includes an active antiperspirant ingredient and a carrier ingredient. The water-in-oil emulsion also includes an oil-phase component that includes a mineral clay emulsifier to stabilize the water-phase component and the oil-phase component. | 2015-07-02 |
| 20150182426 | APPARATUS AND METHOD FOR USING EFFERVESCENT TABLETS FOR COSMETIC CARE - An apparatus and method for providing cosmetic treatment to skin comprise one material chemically active in a solid form preferably in a tablet form and a second material which is chemically reactive with the first material so that effervescence is produced during the reaction. The chemically active materials may be activated by a user for providing cosmetic treatment to skin. The activation releases effervescence which urges granules of the reacting materials onto the skin. The size of the granules lowers during the reaction thus providing continuously refining peeling to the skin. | 2015-07-02 |
| 20150182427 | Silica Abrasive-Free Dentifrice Composition - A dentifrice composition providing superior shine and polish, low RDA and effective whitening comprising a calcined aluminium oxide polishing agent, a water soluble condensed phosphate such as an alkali metal phosphate salt and an orally acceptable carrier or excipient is described. The composition is free of a silica abrasive. | 2015-07-02 |
| 20150182428 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS AND METHODS FOR USING THE SAME - Antiperspirant and deodorant compositions and methods for using the same are provided. In one exemplary embodiment, an antiperspirant and deodorant composition includes an antiperspirant active compound based upon an astringent metallic salt, a skin lubricating agent that reduces a coefficient of friction between skin and a razor blade applied to the skin, and an anti-inflammatory agent that reduces effects of skin irritation and damage. | 2015-07-02 |
| 20150182429 | ANTIPERSPIRANTS WITH LIMITED COATING AGENTS AND METHODS FOR PRODUCING THE SAME - A mixed powder antiperspirant and methods for producing and using such mixed powder antiperspirants are provided. The method includes mixing an active ingredient, a film former, and a diluent to form the mixed powder antiperspirant. The use of a coating agent is limited to no more than about 10 weight percent based on the total weight of the mixed powder antiperspirant, where a coating agent is (i) any non-water soluble wax, oil, fat, or fatty alcohol with a straight chain alkane or alkene group of 10 or more carbon atoms, (ii) polyethylene, or (iii) cyclomethicone. | 2015-07-02 |
| 20150182430 | MULTI-FUNCTIONAL COMPOSITE POWDER - A multi-functional composite poser having the properties of (a) excellent adhesiveness, (b) excellent extendability, (c) an appropriate glossy effect, (d) appropriate covering capability, and (e) excellent soft-focusing capability. The powder is constituted by a scale-like base material, a group of particles including titanium dioxide particles deposited on a part of a surface of the scale-like base material, and a thin film of a composite oxide containing titanium and iron coating part of the surface of the scale-like base material. | 2015-07-02 |
| 20150182431 | Compositions and Methods for Treatment of Hair with Reduced Hair Damage - The present invention relates to hair care compositions comprising select benzylidene 2,4-pentanedione compounds and methods for reducing hair damage, especially oxidative hair damage, arising from various hair treatments. In particular, the compositions according to the present teachings contribute to a reduction or lessening in oxidative damage sustained by hair fibers during bleaching, repeated shampooing, dyeing, perming, straightening and other oxidative treatments. The compositions according to the present invention also provide excellent color evenness, sustained color protection, and reduce scalp itching. | 2015-07-02 |
| 20150182432 | PHENYL KETONE DERIVATIVES AS SELF-TANNING AGENTS - The present invention relates to the use of phenyl ketone derivatives of the formula I for use as self-tanning substance or for increasing melanin synthesis, improving melanin transport and/or improving the distribution of melanin in suprabasal layers, and to preparations comprising these phenyl ketone derivatives. | 2015-07-02 |
| 20150182433 | ANTIPERSPIRANT COMPOSITION WITH A CITRIC ACID STAIN REDUCING AGENT - Materials and apparatus are provided that exhibit increased efficiency. The apparatus includes an antiperspirant composition with a citric acid stain reducing agent. The antiperspirant composition includes a water-in-oil emulsion. The water-in-oil emulsion includes an oil-phase component disposed within the water-in-oil emulsion. The water-in-oil emulsion includes a water-phase component disposed within the water-in-oil emulsion. The water-phase component includes an active antiperspirant ingredient. The water-phase component also includes a citric acid stain reducing agent forming between 0.1 to 8.0 weight percent of the water-in-oil emulsion. | 2015-07-02 |
| 20150182434 | COSMETIC USE OF NAPTHOIC ACID DERIVATIVES - Cosmetic compositions comprising napthoic acid derivatives and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The napthoic acid derivatives are believed to have modulatory activity against one or more biochemical pathways implicated in the appearance of human skin. | 2015-07-02 |
| 20150182435 | COMPOSITION - Conditioning composition comprising from 0.4 to 8% wt. fatty alcohol having from 8-22 carbons, from 0.1 to 2% wt. cationic surfactant component, water, and wherein the composition has a Draw Mass of from 1 to 250g. | 2015-07-02 |
| 20150182436 | DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND METHODS FOR USING THE SAME - The present disclosure provides deodorant compositions having antibacterial and odor blocking properties and methods for using the deodorant compositions. In one embodiment, a deodorant product includes an odor blocking compound that reduces the perceived intensity of malodors or blocks malodors and an antibacterial compound effective to kill bacteria upon application thereto. In another embodiment, a method of deodorizing a malodor includes applying a deodorant product to the skin. The deodorant product includes an odor blocking compound that reduces the perceived intensity of malodors or blocks malodors and an antibacterial compound effective to kill bacteria upon application thereto. | 2015-07-02 |
| 20150182437 | COSMETIC COMPOSITION COMPRISING AN ANIONIC SURFACTANT, A SOLID FATTY ALCOHOL AND A SOLID FATTY ESTER, AND COSMETIC TREATMENT PROCESS - The present invention relates to a cosmetic composition, in particular for conditioning the hair, comprising:—one or more sulphate, sulphonate or carboxylic anionic surfactants comprising a fatty chain,—one or more solid fatty alcohols, and—one or more solid fatty esters. The invention also relates to a process for cosmetic treatment, in particular for conditioning, of keratin materials, in particular sensitized hair, using said composition. | 2015-07-02 |
| 20150182438 | CLEANSING COMPOSITION FOR SKIN OR HAIR - Provided is a cleansing composition for skin or hair capable of bringing about a good rinse feel and durability of foam and, in regard to hair, imparting finger combability during rinsing as well as softness to hair during rinsing and after towel drying, and further, imparting a sufficient moist feeling also to skin after application. A cleansing composition for skin or hair, comprising the following (A) and (B): (A) an internal olefin sulfonate having 12 or more and 24 or less carbon atoms; and (B) a cationic polymer or an amphoteric polymer. | 2015-07-02 |
| 20150182439 | SUNSCREENS - The present invention relates to a composition for topical application comprising in a physiologically acceptable medium at least a benzotriazol derivative, a microfine metal oxide particle and a polymeric emulsifier. More specifically, the invention relates to compositions that exhibit a reduced whitening effect on the skin. | 2015-07-02 |
| 20150182440 | COSMETIC COMPOSITION COMPRISING A HYDROCARBONATED-BASED RESIN, A HYDROCARBON-BASED BLOCK COPOLYMER, A NON VOLATILE DIMETHICONE OIL AND A NON VOLATILE HYDROCARBONATED OIL - The present invention relates to compositions for making up and/or caring for the skin and/or the lips, comprising at least one fatty phase comprising:—at least one hydrocarbon-based resin with a number-average molecular weight of less than or equal to 10 000 g/mol,—at least one hydrocarbon-based block polymer,—from 11% to 80% by weight of non volatile non phenylated silicone oil(s) having at least a dimethicone part, relative to the total weight of the composition, and—from 1% to 80% by total weight of non volatile hydrocarbonated apolar oil(s), relative to the total weight of the composition. | 2015-07-02 |
| 20150182441 | COMPOSITION FOR TREATING KERATINOUS FIBRES, COMPRISING SPECIFIC AMINOSILICONES, ACIDS AND DIRECT DYES - Composition for treating keratinous fibers, more particularly human hair, comprising in a cosmetically appropriate vehicle a) at least one organic and/or inorganic acid, b) at least one direct dye and c) at least one compound of the formula (I). | 2015-07-02 |
| 20150182442 | TRADITIONAL CHINESE MEDICINE COMPOSITION THAT HAS THE EFFECT OF SOOTHING AND CLEANING FACE - The invention provides a traditional Chinese medicine composition that has the effect of soothing and cleaning face, wherein said composition comprises the following servings by weight of the composition ratio of raw material: 5 to 15 servings of water, 2 to 4 servings of decyl glucoside, 1 to 2 servings of lotus extract, 3 to 5 servings of rose oil, 2 to 3 servings of calendula extract, 1 to 2 servings of Witch Hazel extract, 4 to 5 servings of glycerin, 3 to 5 servings of wheat germ extract, 2 to 3 servings of glycoproteins, 1 to 3 servings of citric acid, 2 to 3 servings peony root extract. The compositions can wash the face makeup and impurities, the skin to bring fresh and comfortable feeling, soft, smooth skin feel more compact, soft and moist. | 2015-07-02 |
| 20150182443 | TRADITIONAL CHINESE MEDICINE EXTRACT COMPOSITION WITH WHITENING SKIN-CARE FUNCTION ADN ITS PREPARATION METHOD - The invention provides a raised white skin rejuvenation medicine composition, wherein said composition comprises the following servings by weight of the composition ratio of raw material: 5 to 10 servings of water, 2 to 5 servings of orchids extract, 2 to 3 servings of winter worm of summer, 2 servings of vitamin-C1, 5 servings of almond oil, 2-3 servings of sucrose laurate, 2-3 servings of oat amino acids, 3-4 servings of hyaluronic acid, 2 to 3 servings of Muti pearl, 2 to 3 of | 2015-07-02 |
| 20150182444 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR ANTI-WRINKLE - The invention provides a composition for anti-medicine wrinkle relief, characterized in that said composition comprises the following composition of raw materials in parts by weight: 10-15 parts of water, 5-6 parts of collagen, silk, hydrolyzed 3-5 parts of collagen, milk protein 2-6 copies, copies of the product of yeast fermentation filtrate 3-5, 2-3 parts sucrose laurate, 4-6 parts oil of roses, | 2015-07-02 |
| 20150182445 | DENTAL CLEANING COMPOSITION - Provided are dental cleaning compositions, methods of using and methods of using such compositions which minimize gum damage in the oral cavity. In one form, the dental cleaning composition includes a substantially stoichiometric ratio of one or more oxidizing agents to one or more reducing agents in one or more one or more orally acceptable carriers; where the substantially stoichiometric ratio of one or more oxidizing agents to one or more reducing agents is sufficient to neutralize the oxidizing agent in a subject oral cavity; and where the one or more oxidizing agents and one or more reducing agents are either co-dispensed or sequentially dispensed in the subject oral cavity. | 2015-07-02 |
| 20150182446 | COMPOSITIONS COMRISING SOLUBILIZED ESSENTIAL OILS - Provided are methods for extracting flavor and fragrance materials from natural plant materials, using poly(trimethylene ether) glycol homopolymers and copolymers. The poly(trimethylene ether) glycol homopolymers and copolymers act as solubilizers for essential oils, and can be used to provide compositions having a variety of uses in applications such as cosmetics, personal care products, and industrial cleaning products. | 2015-07-02 |
| 20150182447 | METHOD FOR IMPROVING SKIN CONDITION COMPRISING SIX STEPS AND SYSTEM THEREFOR - The present disclosure relates to a method and a system for skin care using a soap, a lifting pack, an eye cream, a whitening essence, a nourishing cream and a blemish balm or beauty balm cream. By using the six products in sequence, their individual effects can be maximized, thereby providing healthy, bright and transparent skin and restoring skin aging. | 2015-07-02 |
| 20150182448 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR DISPELLING WRINGLES AND BLACK EYE AND ITS PREPARATION METHOD - The invention provides a composition and method for preparing medicine for eye bags and dark circles fade, wherein said composition comprises the following parts by weight ratio of raw material composition: 10-15 parts water, | 2015-07-02 |
| 20150182449 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PIGMENT REPAIR - The invention provides a composition for use in traditional Chinese medicine to repair the pigment, wherein said composition comprises the following parts by weight of the composition ratio of raw material: 5-10 parts water, | 2015-07-02 |
| 20150182450 | STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION - Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer. | 2015-07-02 |
| 20150182451 | CLEANSING COMPOSITION FOR HORMONE DEPOSITION - Materials and apparatus are provided for hormone deposition in a cleansing composition. A cleansing composition includes a number of surfactants disposed within the cleansing composition. The cleansing composition also includes a dermal absorption enhancer disposed within the cleansing composition configured to deposit a hormone onto a skin surface. The cleansing composition also includes a number of hormones disposed within the cleansing composition, in which the number of hormones are configured to be deposited on a skin surface. | 2015-07-02 |
| 20150182452 | LOCAL TREATMENT OF NEUROFIBROMAS - A method for treating a neurofibroma, e.g. dermal neurofibroma, a subdermal neurofibroma, or a superficial plexiform neurofibroma, in a subject in need of such treatment is disclosed. The method comprises locally applying a composition to a neurofibroma either topically or intralesionally. This method does not encompass systemic administration of the composition to the subject to have an effect on the neurofibromas. Compositions useful for such treatments and methods of preparing the compositions are disclosed. | 2015-07-02 |
| 20150182453 | METHODS AND COMPOSITIONS FOR ENHANCING THE VIABILITY OF MICRONEEDLE PORES - Described herein is a method of transdermally administering one or more pharmaceutically active agents to a mammal. The method comprises administering one or more active pharmaceutical agents to the skin of the subject, in conjunction with microneedles and one or more COX inhibitors, whereby the COX inhibitors facilitate the absorption of the active pharmaceutical agents by prolonging the pore opening created by the application of the microneedle. | 2015-07-02 |
| 20150182454 | METHOD OF ADMINISTERING AN INJECTABLE ANTIBIOTIC TO AN ANIMAL - A method of administering an antibiotic to an animal in need thereof, including the step of injecting the antibiotic subcutaneously at the junction of a pinna with the cranium of the animal, is disclosed. | 2015-07-02 |
| 20150182455 | Cannabinoids alcohol mixtures, methods to make and use of the same - The present invention relates to a composition comprising about 0.001% to about 1% by weight of cannabinoids or derivatives thereof, based on the total weight of the mixture, and an alcohol, with water and other compositions as the balance of the weight. The present invention also relates to an alcoholic beverage containing between about 0.001% to about 1% (wt/wt) cannabinoids and derivatives thereof, between about 2% to about 45% (wt/wt) of alcohol, with water, fermentation byproducts, emulsifiers, and flavor enhancers composing the balance of the total weight. The invention also discloses methods to prepare these compositions, and methods of use to minimize adverse effects from alcohol consumption. | 2015-07-02 |
| 20150182456 | HYDROGEL VACCINE FORMULATIONS - This invention relates to compositions for delivering one or more active ingredients, and more particularly to compositions, e.g. beads, comprising a matrix material which matrix material comprises a microorganism. In particular, the invention relates to compositions comprising a microorganism selected from live, killed, attenuated and inactivated microorganisms. The matrix material may also comprise a surfactant and may further comprise an adjuvant. The invention further relates to the manufacture and use of such compositions, and to other subject matter. | 2015-07-02 |
| 20150182457 | Pharmaceutical Compositions For Poorly Water-Soluble Compounds - This present invention is concerned with novel solid dispersion pharmaceutical compositions for preparation of composition which is comprised of a compound with poor water solubility (a weakly basic, neutral and/or non-ionizable, or a weakly acidic compound), water-soluble polymer(s), pH-sensitive polymer(s) (either enteric polymer or gastric-soluble polymer that is soluble at gastric fluid and insoluble at intestine pH range such as Eudragit E), and/or pharmaceutical acceptable surfactant(s) that would improve the solubility/dissolution of the compound in aqueous media of both low and neutral pHs and provide a relative pH-independent dissolution profile. | 2015-07-02 |
| 20150182458 | RUFINAMIDE SOLID DISPERSION - The present invention provides a solid dispersion of rufinamide in combination with a pharmaceutically acceptable carrier, process for its preparation and pharmaceutical compositions comprising it. | 2015-07-02 |
| 20150182459 | STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION - Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket. | 2015-07-02 |
| 20150182460 | LIPOSOMES USEFUL FOR DRUG DELIVERY - The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provides methods of making the liposome compositions provided by the present invention. | 2015-07-02 |
| 20150182461 | Mass Production and Size Control of Nanoparticles Through Controlled Microvortices - Methods for making particles, such as nanoparticles, devices useful in the methods, and particles made by the method are described herein. The methods involves the use of a microfluidic device, such that upon mixing solutions of the materials to form the particles (or a solution of the material or materials to form the particles and a non-solvent for the material or materials), at least two symmetrical microvortices are formed simultaneously. The method can be used to prepare polymeric or non-polymeric particles and hybrid particles, such as lipid-polymer hybrid particles, as well as such particles containing one or more agents associated with the particles. | 2015-07-02 |
| 20150182463 | CONTROLLED ACTIVATION INGESTIBLE IDENTIFIER - Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc. | 2015-07-02 |
| 20150182464 | PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM - The present invention relates to a process for the production of an abuse-proofed solid dosage form containing at least one active ingredient with potential for abuse and a binder with a breaking strength of ≧500 N, by exposing a mixture comprising the active ingredient and the binder to ultrasound and force. | 2015-07-02 |
| 20150182465 | PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM - The present invention relates to a process for the production of an abuse-proofed solid dosage form containing at least one active ingredient with potential for abuse and a binder with a breaking strength of ≧500 N, by exposing a mixture comprising the active ingredient and the binder to ultrasound and force. | 2015-07-02 |
| 20150182466 | Method for Preparing Hydro/Organo Gelators from Disaccharide Sugars by Biocatalysis And Their Use in Enzyme-Triggered Drug Delivery - A method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery. Controlled delivery of an anti-inflammatory, chemopreventive drug is achieved by an enzyme-triggered drug release mechanism via degradation of encapsulated hydrogels. The hydro- and organo-gelators are synthesized in high yields from renewable resources by using a regioselective enzyme catalysis and a known chemopreventive and anti-inflammatory drug, curcumin, is encapsulated in the gel matrix and released by enzyme triggered delivery. The release of the drug occurs at the physiological temperature and control of the drug release rate is achieved by manipulating the enzyme concentration and temperature. The by-products formed after the gel degradation clearly demonstrated the site specificity of degradation of the gelator by enzyme catalysis. The present invention has applications in developing cost effective, controlled drug delivery vehicles from renewable resources, with a potential impact on pharmaceutical research and molecular design and delivery strategies. | 2015-07-02 |
| 20150182468 | STIMULI-RESPONSIVE INTERPOLYMER COMPLEX COATED HOLLOW SILICA VESICLES - A porous hollow silica particle with an interpolymer complex immobilized thereon is provided. The interpolymer complex comprises a first polymer immobilized to a surface of the silica particle, and a second polymer complexed with the first polymer. Pharmaceutical compositions comprising the silica particle, and methods of forming the silica particle are also provided. | 2015-07-02 |
| 20150182469 | Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product - An oral methylphenidate powder which is reconstitutable into a final oral aqueous sustained release formulation containing at least about 50%, or at least about 80% by weight water based on the total weight of the suspension, is provided. The powder is a blend containing a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and a water soluble buffering agent such that upon formed into an aqueous liquid formulation, the formulation has a pH in the range of about 3.5 to about 5, or about 4 to about 4.5. Following administration of a single dose of the oral aqueous methylphenidate suspension, a therapeutically effective amount of methylphenidate is reached in less than one hour and the composition provides a twelve-hour extended release profile. | 2015-07-02 |
| 20150182470 | RECONSTITUTED APOLIPOPROTEIN B LIPOPARTICLE, A PREPARATION METHOD AND USES THEREOF - The present invention provides a method for preparing a reconstituted apolipoprotein B lipoparticle and the method comprises steps of (a) dissolving an apolipoprotein B and a lipid in a first buffer containing 2 M to 8 M urea and 1 wt % to 15 wt % amphiphilic compounds to form a mixture; and (b) dialyzing the mixture against a second buffer containing 0 M to 2M urea and 0 wt % to 0.5 wt % amphiphilic compounds for 1 to several times for lowering concentrations of the urea and the amphiphilic compounds in the mixture. The present invention further provides an apolipoprotein B lipoparticle and a use for the production of an apolipoprotein B lipoparticle used for delivering a hydrophobic substance. | 2015-07-02 |
| 20150182471 | INKJET PRINTING OF TISSUES AND CELLS - Provided herein is an apparatus for printing cells which includes an electrospinning device and an inkjet printing device operatively associated therewith. Methods of making a biodegradable scaffold having cells seeded therein are also provided. Methods of forming microparticles containing one or more cells encapsulated by a substrate are also provided, as are methods of forming an array of said microparticles. | 2015-07-02 |
| 20150182472 | DENATURED LACTOGLOBULIN AND POLYPHENOL COASSEMBLIES - The present invention is directed to co-assembled nanoparticle composition comprising denatured β-lactoglobulin and at least one nutraceutical compound, specifically polyphenols, such as EGCG, compositions comprising same and methods of preparing thereof. | 2015-07-02 |
| 20150182473 | TRANSDERMAL PATCHES WITH DISCRETE CARBON NANOTUBES - A transdermal patch comprising discrete open-ended carbon nanotubes is disclosed. | 2015-07-02 |
| 20150182474 | DISPOSAL SYSTEM FOR TRANSDERMAL DOSAGE FORM - The present invention relates to a disposable article to prevent the misuse of a transdermal dosage form (FIG. | 2015-07-02 |
| 20150182475 | THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID COMPOSITION AND ASSOCIATED METHOD - A dietary supplement includes comprising a therapeutic amount of astaxanthin derived from a synthetic or natural ester or diol, and at least one of a phospholipid, glycolipid, and sphingolipid, and formulated into an oral dosage form, wherein the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. The composition includes 0.5 to 12 mg of astaxanthin and may be used to treat low density lipoprotein (LDL) oxidation in humans and other diseases, disorders and impairments. | 2015-07-02 |
| 20150182476 | Propynylaminoindan Transdermal Compositions - Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix of the propynylaminoindan in a pressure sensitive adhesive comprising a carboxylated polymer. In some instances, the matrix further includes a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions. | 2015-07-02 |
| 20150182477 | Compositions and Methods for Treating Alzheimers Disease - Pharmaceutical compositions for treating Alzheimer's disease are disclosed. The pharmaceutical compositions include a compound having the general formula: | 2015-07-02 |
| 20150182478 | CHEWABLE TABLET CONTAINING PHENYLEPHRINE - A chewable pharmaceutical composition comprising phenylephrine, artificial sweetener, and a substantially aldehyde-free matrix is provided. The composition has phenylephrine stability suitable for a typical commercial product with a two year shelf life. A method of manufacture of the composition and a method of use are also provided. | 2015-07-02 |
| 20150182479 | Method of delivering agmatine for medical treatment - The present invention is directed to a method of delivering agmatine to a human for medicinal treatment, which includes: a.) providing a spray dispenser with an agmatine solution containing agmatine in a liquid carrier, the spray dispenser having a dispensing nozzle; and, b.) positioning the dispensing nozzle of the spray dispenser adjacent a nasal cavity of the human and spraying an effective amount of the agmatine solution into the nasal cavity so as to penetrate an olfactory area of the human. | 2015-07-02 |
| 20150182480 | Methods and Pharmaceutical Compositions for Treatment of Cystic Fibrosis - The present invention relates to a method and compositions for the treatment of cystic fibrosis. | 2015-07-02 |
| 20150182481 | USE OF POLYMER D-LACTIC ACID (PDLA) TO TREAT PAIN - L-Lactate is required as a fuel for the continuous firing of nociceptors that produce many of the manifestations of chronic pain. Polymer D-lactic acid (PDLA) forms a spontaneous non-enzymatic, thermodynamically favored stereocomplex with sequestration of l-lactate or “trapping” of l-lactate. Injection or topical application of PDLA can reduce pain by decreasing the l-lactate available to activated nociceptors without sequestering lactate in non-disrupted nerves. C fibers and unmyelinated visceral afferents are most sensitive to the analgesia produced by PDLA. PDLA can be used to ameliorate pain from a wide variety of medical conditions including skin ulcers, wounds and burns; causalgia, radiculopathy, neuropathy; arthritis; and cancer. PDLA oligomers can be inexpensively produced from d-lactic acid in a home microwave. The predicted toxicity of PDLA is low and topical application or injection into perineural tissues for relief of pain may be very safe. | 2015-07-02 |
| 20150182482 | EPROTIROME FOR USE IN THE PREVENTION AND/OR TREATMENT OF HAIR DISORDERS AND COMPOSITIONS THEREOF - The use of eprotirome in the prevention and/or treatment of hair disorders is herein disclosed. | 2015-07-02 |
| 20150182483 | GLYCATION OF L-LYSINE TO LOWER BLOOD GLUCOSE AND TREAT COMPLICATIONS OF DIABETES - Control of blood glucose is a fundamental goal in the treatment of diabetes mellitus. Glycation of l-lysine can lower blood glucose and advanced glycation end product (AGE) free adducts can be excreted in the urine. Lysine, an inexpensive amino acid, can be administered orally or parentally, and can be incorporated into a stereocomplex matrix as a time released preparation. In patients who suffer from diabetes and concomitant renal insufficiency who cannot clear sufficient quantities of AGE free adducts enantiomeric mixtures of lysine will lower blood glucose and AGEs since d-lysine has been shown to decrease protein glycation and lower hemoglobin Alc. This invention is not intended to replace insulin or oral hypoglycemic agents but is does offer patients a low cost and probably safe complementary therapy for the treatment of diabetes mellitus. In addition to the treatment of diabetes and its complications, this invention could lower AGE burden and slow or ameliorate some of the consequences of aging. | 2015-07-02 |
| 20150182484 | Levothyroxine Formulations - A levothyroxine composition includes levothyroxine sodium and mannitol. The composition is a lyophilized solid. The composition may include from 100 to 500 micrograms levothyroxine sodium and from 2 to 4 milligrams mannitol. | 2015-07-02 |
| 20150182485 | FISH FEED, METHODS FOR PREPARING FEED, AND FEEDING FISH - Fish feed, methods for preparing feed, and methods of providing feed to fish are described herein. A method of providing feed to fish may include providing a first feed composition to the fish prior to the fish growing to a weight of about 50% to about 90% of a desired body weight and providing a second feed composition to the fish after the fish grows to a weight of about 50% to about 90% of the desired body weight. The first feed composition may include a first concentration of at least one of eicosapentaenoic acid and docosahexaenoic acid. The second feed composition may include a second concentration of at least one of eicosapentaenoic acid and docosahexaenoic acid. The second concentration may be at least about 30% greater than the first concentration. | 2015-07-02 |
| 20150182486 | COMPOSITION CONTAINING DIHOMO-y-LINOLENIC ACID (DGLA) AS THE ACTIVE INGREDIENT - The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-γ-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-γ-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-γ-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count. | 2015-07-02 |
| 20150182487 | COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES AND IMMUNE DISEASES, CONTAINING APO-9`-FUCOXANTHINONE AS ACTIVE INGREDIENT - The present invention relates to a composition for preventing and treating inflammatory diseases and immune diseases, containing a | 2015-07-02 |
| 20150182488 | METHODS FOR TREATING INFLAMMATION AND PAIN - The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an ω-(methanesulfonyl)alkenylnitrile compound, or a pharmaceutically acceptable salt thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering an ω-(methanesulfonyl)alkenylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. Oral and topical administration are preferred. | 2015-07-02 |
| 20150182489 | GOLD (III) COMPOUNDS AND USE FOR TREATING CANCER - Metallodrugs including gold (III) compound with various polydentate ligands, the renal and hepatic toxicity of gold (III) compounds with various polydentate ligands, an antineoplstic drug containing the gold (III) compound [Au(en)Cl | 2015-07-02 |
| 20150182490 | METHODS FOR TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS EMPLOYING DIANHYDROGALACTITOL, DIACETYLDIANHYDROGALACTITOL, DIBROMODULCITOL, OR ANALOGS OR DERIVATIVES THEREOF - Methods and compositions suitable for the treatment of malignancies in subjects with a germline deletion polymorphism that blocks the activity of thymidine kinase inhibitors in triggering apoptosis in tumor cells or in subjects having a mutation in or a dysregulation of the AHI1 gene are disclosed. These methods employ an alkylating hexitol derivative such as dianhydrogalactitol, a derivative or analog of dianhydrogalactitol, diacetyldianhydrogalactitol, a derivative or analog of diacetyldianhydrogalactitol, dibromodulcitol, and a derivative or analog of dibromodulcitol. The compositions can include such alkylating hexitol derivatives. The methods can further include administration of a BH3 mimetic, and the compositions can further include a BH3 mimetic. In subjects having a dysregulation of the AHI1 gene, the methods can further include the administration of an agent modulating the expression or activity of the AHI1 gene or AHI1 protein, and the compositions can further include such an agent. | 2015-07-02 |
| 20150182491 | METHOD FOR TREATING VIRUS INFECTION USING DERIVATIVE OF ANILINE - A method for treating a virus infection in a subject is provided. The method comprising administering to the subject in need an effective amount of a derivative of aniline selected from the group consisting of a compound of formula (I), a pharmaceutically acceptable salt of the compound of formula (I), a pharmaceutically acceptable ester of the compound of formula (I), and combinations thereof: | 2015-07-02 |
| 20150182492 | Ulcer Treatment - The present invention relates to the treatment of peptic ulcers. In particular, the present invention provides methods and compositions for the treatment of peptic ulcers. In addition, the present invention provides a method of reducing gastric acid secretion in a subject. | 2015-07-02 |
| 20150182493 | Methods for Treating Burn and Scar Injury using Tocotrienol Compositions - The present invention provides methods to improve scar and burn outcome utilizing tocotrienols. In particular, various skin pathologies may be treated using the present methods. The present invention also provides methods to increase skin tissue concentrations of tocotrienols. | 2015-07-02 |
| 20150182494 | METHOD OF MANAGING DIABETIC FOOT ULCERS, PRESSURE ULCERS, VENOUS LEG ULCERS AND ASSOCIATED COMPLICATION - The present disclosure is related to a method of managing diabetic foot ulcers (DFUs), pressure ulcers, venous leg ulcers and associated complications such as bacterial infection, gangrene, tissue necrosis, amputation, proximal limb loss and septicaemia. This method of managing is by administration of pharmaceutical composition comprising pentameric type A procyanidin, trimeric procyanidin and tetrameric procyanidin, optionally along with pharmaceutically acceptable excipient. | 2015-07-02 |
| 20150182495 | Methods and Compositions for Treating Pain - Methods and compositions are provided for treating pain in an individual. Aspects of the methods include administering to the individual an agent that promotes ALDH activity. These methods find many uses, for example in treating and preventing nociceptive pain, inflammatory pain, and neuropathic pain. | 2015-07-02 |
| 20150182496 | MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER - The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I): | 2015-07-02 |
| 20150182497 | COMPOUNDS FOR USE IN THE TREATMENT OF FILARIASIS - A method for a therapeutic treatment of filariasis includes administering to a subject in need thereof an effective amount of a compound of the general formula (1) | 2015-07-02 |
| 20150182498 | COMPOUNDS FOR USE IN THE TREATMENT OF FILARIASIS - A method for the prevention of filariasis includes administering to a subject a therapeutically effective amount of a compound of the general formula (1) | 2015-07-02 |
| 20150182499 | USE OF COUMARIN DERIVATIVES FOR THE PREPARATION OF DRUGS FOR TREATING SKIN DISEASES - A compound of formula (I-1) | 2015-07-02 |
| 20150182500 | COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK - The present invention relates to a composition comprising (i) choline and (ii) a compound selected from the group consisting of palmitate, vitamin C and vitamin E for use in treating or preventing metabolic stress-induced lung injury and a method for increasing physical capacity of mammalian livestock comprising administering to the mammalian livestock the above composition. | 2015-07-02 |
